Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 17,34117,360 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Five-year survival rate of pancreatic ductal adenocarcinoma (PDAC) still remains at a dismal 10%. This poor outcome is attributed to PDAC’s complex tumor m...

$4.25M
USD
Completed NON-SBIR/STTR RPGS
Molecular and immunological heterogeneity of Small Cell Lung Cancer (SCLC) and its impact on relapse and therapeutic response
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

PROJECT SUMMARY Small cell lung cancer (SCLC) is an aggressive malignancy for which there is a critical need for improved therapeutic strategies. While targeted and immune-based th...

$5.93M
USD
Completed SBIR-STTR RPGS
PRANAYAMA BASED MOBILE APP FOR BREAST CANCER SURVIVORSHIP: I-CORPS SUPPLEMENT
NATIONAL CANCER INSTITUTE Pranascience Institute Llc United States 2021 – 2023

PROJECT SUMMARY Cancer remains the second leading cause of deaths in the U.S. Encouragingly, recent improvements in early diagnosis and treatment has led to significant increases i...

$550K
USD
Completed NON-SBIR/STTR RPGS
Sensitizing Ovarian Cancer To PARP inhibitor and platinum treatment
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2021 – 2026

Abstract Homologous recombination (HR) is an important DNA repair mechanism for DNA damage caused by PARPi and platinum. The HR pathway is closely associated with ovarian cancer de...

$3.56M
USD
Completed NON-SBIR/STTR RPGS
The Impact of Cigarillo Warnings on Purchasing and Smoking Behaviors Among Young Adult Cigarillo Users
NATIONAL CANCER INSTITUTE Boston University Medical Campus United States 2021 – 2024

Project Summary Cigarillo use remains a public health concern, particularly among vulnerable populations. Young adults, including those who are Black or African American, have the...

$3.14M
USD
Completed OTHER RESEARCH-RELATED
Lipid-based Cancer Therapeutics
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2023

Project Summary Significant progress in human cancer therapy in the last decade has been driven by conceptionally new approaches to targeting cancer, including cancer immunotherapy...

$859.6K
USD
Completed OTHER RESEARCH-RELATED
Expanding pharmacological modalities for targeted cancer therapy
NATIONAL CANCER INSTITUTE Broad Institute, Inc United States 2021 – 2025

Project Summary/Abstract Targeted cancer therapy requires complete and sustained pharmacological inhibition of the respective target, which is often challenging to achieve due to t...

$966.3K
USD
Completed OTHER RESEARCH-RELATED
The immunosuppressive function of secretory IgM in tumor-bearing mice
NATIONAL CANCER INSTITUTE Methodist Hospital Research Institute United States 2021 – 2024

Project Summary/Abstract Myeloid-derived suppressor cells (MDSCs) exert potent immunosuppressive functions within tumor microenvironments to promote tumor growth. It is critical to...

$1.94M
USD
Completed TRAINING, INDIVIDUAL
Molecular and cancer-related roles of ACLY exon 14
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2025

Project Summary The goal of this proposal is to understand the molecular role of alternative splicing and phosphorylation of ATP- citrate lyase (ACLY) exon 14 and how these events...

$467.5K
USD
Completed TRAINING, INDIVIDUAL
Bacterial Rogue Methyltransferases Inducing Human Epimutations
NATIONAL CANCER INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2021 – 2022

PROJECT SUMMARY: DNA methylation is dysregulated in every form of cancer. While there is substantial knowledge regarding the location and function of abnormal DNA methylation acros...

$214.3K
USD
Completed NON-SBIR/STTR RPGS
Leveraging the TCR Repertoire to identify target neoantigens in FLT3-ITD positive Acute Myeloid Leukemia
NATIONAL CANCER INSTITUTE University of Southern California United States 2021 – 2026

Abstract Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative treatment for patients with high- risk acute myeloid leukemia (AML). However, HSCT is affect...

$3.52M
USD
Completed NON-SBIR/STTR RPGS
Treating colon cancer by regulating intestinal immunity through microbial metabolism
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2021 – 2026

PROJECT SUMMARY Colorectal cancer (CRC) is profoundly affected by the intestinal immune system and the intestinal microbiome, which can exert both pro- and anti-cancer effects that...

$5.54M
USD
Completed TRAINING, INDIVIDUAL
Elucidating the Role of Epigenetic Plasticity in anti-GD2 Immunotherapy Response
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2024

Project Summary (from the funded application) Ganglioside GD2 is expressed on the cell surface of numerous pediatric cancers, including Ewing sarcoma, osteosarcoma, and neuroblasto...

$25K
USD
Completed NON-SBIR/STTR RPGS
Characterizing and Targeting BAX- and BAK-Dependent Cell Death in Cancer
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

PROJECT SUMMARY The incorporation of Immune checkpoint blockade into anticancer armamentarium has revolutionized cancer therapy in recent years, with FDA approved agents in multipl...

$5.03M
USD
Completed NON-SBIR/STTR RPGS
Endometrial epithelial stem cells and cancer
NATIONAL CANCER INSTITUTE Cornell University United States 2021 – 2026

Uterine cancer is the 4th most frequent malignancy and the 6th cause of cancer-related deaths in women in the US. While the incidence and mortality rates of some cancers, such as l...

$4.25M
USD
Completed NON-SBIR/STTR RPGS
Socio-environmental context in monoclonal gammopathy of undetermined significance (MGUS) disparities
NATIONAL CANCER INSTITUTE Boston University Medical Campus United States 2021 – 2026

ABSTRACT Compared to non-Hispanic whites, African Americans have a more than 2-fold higher incidence of multiple myeloma (MM) and its asymptomatic precursor condition, monoclonal g...

$6.85M
USD
Completed NON-SBIR/STTR RPGS
Analysis and Therapeutic Targeting of the Linear-Ubiquitination Pathway in Hodgkin Lymphoma
NATIONAL CANCER INSTITUTE Research Inst of Fox Chase Can Ctr United States 2021 – 2026

PROJECT SUMMARY Hodgkin lymphoma (HL) is the most common (6,000 to 7,000 new cases per year) lymphoma subtype in young adulthood. Although there has been great progress during the...

$4.19M
USD
Completed NON-SBIR/STTR RPGS
Novel Perceptual and Oculomotor Heuristics for Enhancing Radiologic Performance
NATIONAL CANCER INSTITUTE Suny Downstate Medical Center United States 2021 – 2026

PROGRAM SUMMARYRadiological imaging is often the first step of the diagnostic pathway for many devastating diseases; thus, an erroneous assessment of “normal” can lead to death. Wh...

$5.56M
USD
Completed NON-SBIR/STTR RPGS
Enhancement of ADC selectivity by inverse targeting: Mechanistic studies and optimization
NATIONAL CANCER INSTITUTE State University of New York At Buffalo United States 2021 – 2026

Cancer is a major cause of morbidity and mortality in the US, with 1.8 million cases and 600 thousand cancer deaths projected for 2020. Substantial progress in cancer treatment has...

$3.67M
USD
Completed OTHER RESEARCH-RELATED
Investigating the biology and therapeutic vulnerabilities of ER+ metastatic breast cancer with activating HER2 mutations
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2025

Project Summary/Abstract The candidate, Ms. Utthara Nayar, PhD, is a translational cancer biologist, and currently a Research Fellow in Medicine at Dana-Farber Cancer Institute, Ha...

$1.89M
USD